The Precision Peptide Genetic Test offered by PlexusDx identifies your unique GIPR genetic variants, which partially determine how strongly you respond to tirzepatide and when your body's appetite pathways are most active
An observational study published in 2023 in Diabetes Care that looked to determine whether the use of GLP-1 medications was associated with an increased risk of thyroid cancer found that in 1-3 years of treatment, the risk for thyroid cancer was increased for those taking GLP-1 medications (2)
It may help people who fit specific criteria to lose weight, manage their blood sugar, and reduce the risk of other health complications related to weight or diabetes
Clinical Trials and Studies on Semaglutide: Aroda, V
Genetic Predisposition Some people have a genetic predisposition to kidney problems, including infections
Its review would address safety, effectiveness, and quality